No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
PYXS250117C2500
- 0.05
- 0.000.00%
15min DelayTrading Dec 23 09:32 ET
0.05High0.05Low
0.05Open0.05Pre Close1 Volume11.28K Open Interest2.50Strike Price5.00Turnover147.55%IV55.96%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1756Delta0.4135Gamma32.70Leverage Ratio-0.0032Theta0.0002Rho5.74Eff Leverage0.0011Vega
Intraday
- 5D
- Daily
News
RBC Capital Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Cuts Target Price to $8
H.C. Wainwright Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Cuts Target Price to $5
LifeSci Capital Maintains Pyxis Oncology(PYXS.US) With Buy Rating
Pyxis Oncology's Deprioritizes Second Pipeline Asset, Analyst Applauds Move
Express News | Pyxis Oncology, Inc. : H.c. Wainwright Cuts Target Price to $5 From $7
Pyxis Oncology Analyst Ratings